Evidence map›Paper›PMID 32510628›Full record

ArticleClinical transplantation2020

Outcome implications of benzodiazepine and opioid co-prescription in kidney transplant recipients.

Ngan N Lam, Mark A Schnitzler, David A Axelrod, Huiling Xiao, Mara McAdams-DeMarco, Dorry L Segev, Allan B Massie, Vikas R Dharnidharka, Abhijit S Naik, Abimereki D Muzaale and 3 more

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical transplantation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Survival implications of prescription opioid and benzodiazepine use in lung transplant recipients: Analysis of linked transplant registry and pharmacy fill records.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 2 countries.

Ngan N LamDepartment of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.ORCID 0000-0002-0129-7091
Mark A SchnitzlerCenter for Abdominal Transplantation, Saint Louis University School of Medicine, St. Louis, MO, USA.
David A AxelrodUniversity of Iowa Transplant Center, Iowa City, IA, USA.ORCID 0000-0001-5684-0613
Huiling XiaoCenter for Abdominal Transplantation, Saint Louis University School of Medicine, St. Louis, MO, USA.
Mara McAdams-DeMarcoDepartment of Surgery, Johns Hopkins School of Medicine, Baltimore, MD, USA.ORCID 0000-0003-3013-925X
Dorry L SegevDepartment of Surgery, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Allan B MassieDepartment of Surgery, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Vikas R DharnidharkaDepartment of Pediatrics, Washington University School of Medicine, St. Louis, MO, USA.
Abhijit S NaikDivision of Nephrology, Department of Medicine, University of Michigan, Ann Arbor, MI, USA.ORCID 0000-0003-1602-9425
Abimereki D MuzaaleDepartment of Surgery, Johns Hopkins School of Medicine, Baltimore, MD, USA.ORCID 0000-0002-3287-6061
Gregory P HessDivision of Nephrology, Department of Medicine, University of Michigan, Ann Arbor, MI, USA.
Bertram L KasiskeDivision of Nephrology, Hennepin County Medical Center, Minneapolis, MN, USA.
Krista L LentineCenter for Abdominal Transplantation, Saint Louis University School of Medicine, St. Louis, MO, USA.ORCID 0000-0002-9423-4849
Johns Hopkins University · USSaint Louis University · USUniversity of Michigan · USHennepin County Medical Center · USUniversity of Calgary · CAUniversity of Iowa · USWashington University in St. Louis · US

Funding

Developing personalized immunosuppression for older kidney transplant recipientsR01DK120518 · NIDDK · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI MCADAMS DEMARCO, MARA A. · 2019 to 2022
$2.7M
Choosing Immune Suppression in Renal Transplantation by Efficacy and MorbidityR01DK102981 · NIDDK · WASHINGTON UNIVERSITY · PI DHARNIDHARKA, VIKAS R. · 2014 to 2018
$1.9M
NIDDK NIH HHS R01 DK102981NIDDK NIH HHS R01 DK120518
6 · The paper itself

Abstract

The outcomes of benzodiazepine and opioid co-prescription are not well-defined in transplant populations. We examined linked national transplant registry and pharmaceutical records to characterize benzodiazepine and opioid use in the years before and after transplant in large US cohort of kidney transplant recipients (2007-2016; N = 98 620), and associations (adjusted hazard ratio,

Indexed as

Analgesics, OpioidKidney TransplantationBenzodiazepinesHumansRetrospective StudiesRisk FactorsTransplant RecipientsAnalgesics, OpioidBenzodiazepinesbenzodiazepineskidney transplantationopioidsregistriesrisk factors

Identifiers

PMID32510628
PMCPMC7722087
OpenAlexW3033645242

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.